Showing results (121-130 of 138) with videos related to
Sort By:
Pageof 14
Frontiers in Plant Science|March 9, 2023
Apomictic <i>Malus</i> plants exhibit abnormal pollen developmentDan-Dan Liu, Da-Ru Wang, Xuan-Yu Yang, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 20, 2010
Epidemiology of hand, foot, and mouth disease and genotype characterization of Enterovirus 71 in Jiangsu, ChinaLing-Xiang Mao, Bing Wu, Wu-Xin Bao, et al.The EMBO Journal|September 10, 2024
The global phosphorylation landscape of mouse oocytes during meiotic maturationHongzheng Sun, Longsen Han, Yueshuai Guo, et al.In Vivo (Athens, Greece)|July 2, 2014
Antioxidant effects of lipophilic tea polyphenols on diethylnitrosamine/phenobarbital-induced hepatocarcinogenesis in ratsFan Zhou, Ting Shen, Ting Duan, et al.European Journal of Pharmacology|May 10, 2023
Discovery of a highly potent pan-RAF inhibitor IHMT-RAF-128 for cancer treatmentAoli Wang, Juan Liu, Xixiang Li, et al.Chinese Medical Journal|September 17, 2013
Pneumonia relevant to lung transplantation and pathogen distributionXuan He, Hua-Ping Dai, Qi-Rui Chen, et al.Chinese Medical Journal|July 18, 2023
Heterozygous CARD9 mutation favors the development of allergic bronchopulmonary aspergillosisXia Xu, Haiwen Lu, Jianxiong Li, et al.Cell Death and Differentiation|April 28, 2025
FTDC1/2, oocyte-specific cofactors of DNMT1 required for epigenetic regulation and embryonic developmentCongyang Li, Jiashuo Li, Siyu Du, et al.European Journal of Medicinal Chemistry|July 28, 2018
Discovery of (S)-2-amino-N-(5-(6-chloro-5-(3-methylphenylsulfonamido)pyridin-3-yl)-4-methylthiazol-2-yl)-3-methylbutanamide (CHMFL-PI3KD-317) as a potent and selective phosphoinositide 3-kinase delta (PI3Kδ) inhibitorXiaofei Liang, Feng Li, Cheng Chen, et al.Acta Pharmacologica Sinica|March 1, 2022
CHMFL-26 is a highly potent irreversible HER2 inhibitor for use in the treatment of HER2-positive and HER2-mutant cancersJiang-Yan Cao, Shuang Qi, Hong Wu, et al.Pageof 14